• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients.

作者信息

Björkman S, Wada D R, Stanski D R

机构信息

Hospital Pharmacy, Malmö University Hospital, Sweden.

出版信息

Anesthesiology. 1998 Mar;88(3):657-67. doi: 10.1097/00000542-199803000-00016.

DOI:10.1097/00000542-199803000-00016
PMID:9523809
Abstract

BACKGROUND

The influence of changes in the physiologic state of a patient on the disposition of fentanyl and alfentanil is poorly understood. The aims of this study were to determine whether physiologic pharmacokinetic models for fentanyl and alfentanil, based on data from rats, could predict plasma concentrations of these opioids in humans and to determine how changes in physiology would influence the predictions of their disposition.

METHODS

The predictions of the models were tested against plasma concentration data from published pharmacokinetic studies. The influences of changes in body composition, cardiac output, and regional blood flows on the disposition of the opioids were simulated.

RESULTS

The models could predict independently measured plasma concentrations of the opioids after short infusions in humans. Simulations then predicted that differences in body composition between men and women would have little influence on the pharmacokinetics of the opioids. Changes in cardiac output would affect drug redistribution, and consequently the early decay of the plasma concentrations, but not markedly influence rates of elimination. Further, the clearance of the opioids would decrease and their volumes of distribution increase with the age of the patient, but this would only marginally affect the early disposition of the drugs. Even large fluctuations in peripheral or hepatic blood flows would have modest effects on arterial plasma concentrations of the opioids, and sudden "postoperative" increases in peripheral blood flows would cause minor secondary plasma concentration peaks.

CONCLUSIONS

The ability of the physiologic models to predict plasma concentrations of fentanyl and alfentanil in humans was confirmed. When changes in physiologic condition were simulated, effects on the pharmacokinetics of the opioids with possible implications for dosing were obtained only if cardiac output was varied over a wide range.

摘要

相似文献

1
Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients.
Anesthesiology. 1998 Mar;88(3):657-67. doi: 10.1097/00000542-199803000-00016.
2
Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats.
Anesthesiology. 1990 May;72(5):865-73. doi: 10.1097/00000542-199005000-00017.
3
Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models.基于参数化单组织模型的大鼠和人类中芬太尼与阿芬太尼的比较生理药代动力学
J Pharmacokinet Biopharm. 1994 Oct;22(5):381-410. doi: 10.1007/BF02353862.
4
Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model.芬太尼和阿芬太尼在大鼠体内的组织分布不能用血流限制模型来描述。
J Pharmacokinet Biopharm. 1993 Jun;21(3):255-79. doi: 10.1007/BF01059779.
5
Simultaneous assessment of drug interactions with low- and high-extraction opioids: application to parecoxib effects on the pharmacokinetics and pharmacodynamics of fentanyl and alfentanil.低萃取率和高萃取率阿片类药物药物相互作用的同步评估:帕瑞昔布对芬太尼和阿芬太尼药代动力学和药效学影响的应用
Anesthesiology. 2003 Apr;98(4):853-61. doi: 10.1097/00000542-200304000-00011.
6
Understanding pharmacokinetics and pharmacodynamics through computer stimulation: I. The comparative clinical profiles of fentanyl and alfentanil.通过计算机模拟理解药代动力学和药效学:I. 芬太尼和阿芬太尼的比较临床概况。
Anesthesiology. 1990 Apr;72(4):650-8. doi: 10.1097/00000542-199004000-00013.
7
Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.阿芬太尼、芬太尼和舒芬太尼的临床药代动力学。最新进展。
Clin Pharmacokinet. 1996 Oct;31(4):275-92. doi: 10.2165/00003088-199631040-00004.
8
Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil.药物研发中的药代动力学-药效学建模:在研究性阿片类药物曲 fentanil 中的应用。
Clin Pharmacol Ther. 1994 Sep;56(3):261-71. doi: 10.1038/clpt.1994.136.
9
Alfentanil causes less postoperative nausea and vomiting than equipotent doses of fentanyl or sufentanil in outpatients.在门诊患者中,与等效剂量的芬太尼或舒芬太尼相比,阿芬太尼引起的术后恶心和呕吐更少。
Anesthesiology. 1999 Dec;91(6):1666-73. doi: 10.1097/00000542-199912000-00019.
10
Pharmacokinetic parameters relevant to recovery from opioids.与阿片类药物恢复相关的药代动力学参数。
Anesthesiology. 1994 Oct;81(4):833-42. doi: 10.1097/00000542-199410000-00010.

引用本文的文献

1
Assessing the developmental effects of fentanyl and impacts on lipidomic profiling using neural stem cell models.使用神经干细胞模型评估芬太尼的发育影响及其对脂质组学分析的影响。
Exp Biol Med (Maywood). 2025 Jun 25;250:10607. doi: 10.3389/ebm.2025.10607. eCollection 2025.
2
Anesthetic Considerations in Athletes: A Review.运动员的麻醉注意事项:综述
Cureus. 2025 Mar 23;17(3):e81040. doi: 10.7759/cureus.81040. eCollection 2025 Mar.
3
Risk Factors for Chronic Abdominal Pain After RYGB: Are Patients Adequately Selected Beforehand?
胃旁路术后慢性腹痛的风险因素:患者术前是否得到充分选择?
Obes Surg. 2024 May;34(5):1748-1755. doi: 10.1007/s11695-024-07193-6. Epub 2024 Apr 5.
4
Cross-sectional E-survey on the Incidence of Pre- and Postoperative Chronic Pain in Bariatric Surgery.横断面电子调查肥胖症手术患者术前和术后慢性疼痛的发生率。
Obes Surg. 2023 Jan;33(1):204-210. doi: 10.1007/s11695-022-06354-9. Epub 2022 Nov 8.
5
A review on the anesthetic management of obese patients undergoing surgery.肥胖患者手术的麻醉管理综述。
BMC Anesthesiol. 2022 Apr 5;22(1):98. doi: 10.1186/s12871-022-01579-8.
6
Predicting transdermal fentanyl delivery using physics-based simulations for tailored therapy based on the age.基于年龄的个性化治疗,使用基于物理的模拟预测经皮芬太尼传递。
Drug Deliv. 2022 Dec;29(1):950-969. doi: 10.1080/10717544.2022.2050846.
7
Obesity and anesthetic pharmacology: simulation of target-controlled infusion models of propofol and remifentanil.肥胖与麻醉药理学:丙泊酚和瑞芬太尼靶控输注模型的模拟。
Korean J Anesthesiol. 2021 Dec;74(6):478-487. doi: 10.4097/kja.21345. Epub 2021 Aug 18.
8
Pharmacokinetics of anaesthetic drugs at extremes of body weight.极端体重下麻醉药物的药代动力学。
BJA Educ. 2018 Dec;18(12):364-370. doi: 10.1016/j.bjae.2018.09.001. Epub 2018 Oct 26.
9
Effect of different surgical procedures on the accuracy of prediction of the plasma concentration of fentanyl: comparison between mastectomy and laparoscopic prostatectomy.不同手术方式对芬太尼血浆浓度预测准确性的影响:乳房切除术与腹腔镜前列腺切除术的比较
JA Clin Rep. 2017;3(1):30. doi: 10.1186/s40981-017-0097-2. Epub 2017 May 19.
10
Pain Experience and Perception in the Obese Subject Systematic Review (Revised Version).肥胖受试者的疼痛体验与感知:系统评价(修订版)
Obes Surg. 2016 Mar;26(3):631-9. doi: 10.1007/s11695-015-2008-9.